SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Procter&Gamble Healt - Quaterly Results

29 May 2025 Evaluate
The revenue for the March 2025 quarter is pegged at Rs. 3109.90 millions, about 23.17% up against Rs. 2524.80 millions recorded during the year-ago period.A comparatively good net profit growth of 31.40% to Rs. 611.80 millions was reported for the quarter ended March 2025 compared to Rs. 465.60 millions of previous same quarter.Operating profit surged to 840.30 millions from the corresponding previous quarter of 697.10 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202406 202306 % Var
Sales 3109.90 2524.80 23.17 9341.70 8673.80 7.70 11512.60 12296.20 -6.37
Other Income 31.10 22.70 37.00 103.50 135.00 -23.33 156.30 183.90 -15.01
PBIDT 840.30 697.10 20.54 3287.40 2712.50 21.19 3216.30 3430.70 -6.25
Interest 1.30 1.50 -13.33 4.30 5.20 -17.31 7.20 7.70 -6.49
PBDT 839.00 695.60 20.62 3283.10 2707.30 21.27 3007.20 3423.00 -12.15
Depreciation 53.70 68.40 -21.49 166.90 202.40 -17.54 274.00 281.00 -2.49
PBT 785.30 627.20 25.21 3116.20 2504.90 24.40 2733.20 3142.00 -13.01
TAX 173.50 161.60 7.36 772.10 662.90 16.47 723.40 847.30 -14.62
Deferred Tax -33.60 -1.40 2300.00 -4.90 -18.60 -73.66 -86.00 -50.60 69.96
PAT 611.80 465.60 31.40 2344.10 1842.00 27.26 2009.80 2294.70 -12.42
Equity 166.00 166.00 0.00 166.00 166.00 0.00 166.00 166.00 0.00
PBIDTM(%) 27.02 27.61 -2.14 35.19 31.27 12.53 27.94 27.90 0.13

Procter&Gamble Healt Share Price

4972.65 29.00 (0.59%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×